Injective drops 8.37% as price pulls back from overbought territory

Traders Union
All News
Crypto News
Injective drops 8.37% today to $5.45

Highlights

Injective integrated native USDC support, granting users direct access to Circle’s regulated stablecoin liquidity within its ecosystem.
This expansion enables smoother transactions for tokenized stocks, pre-IPO assets, and DeFi applications, enhancing Injective’s role in tokenized finance.
Despite enhanced infrastructure, INJ faces broad selling pressure, with technicals signaling a sideways to downward bias and a five-day price corridor of $5.28–$5.77.

Ecosystem expansion through USDC integration amid ongoing sell-off

Injective launched native USDC support on its network, enabling direct access to Circle’s regulated stablecoin liquidity within the ecosystem. This integration aims to facilitate transactions involving tokenized stocks, pre-IPO assets, and decentralized finance applications by expanding the network’s financial infrastructure and supporting broader use cases. The recent development further supports Injective’s position within the tokenized finance and stablecoin sectors, though price action has remained under broader selling pressure.

Overbought signals and indicator divergence as bullish trend faces tests

Technically, INJ’s price stands above the SMA-20 ($4.96), SMA-50 ($4.02), and SMA-200 ($4.26), with the D1 Ichimoku Kijun level at $4.88 acting as immediate support. Short-term support is reinforced near $4.88, while resistance lies toward the upper $5.70s region. On the daily timeframe, MACD and ADX reflect continued bullish setups, but RSI at 63.62 and CCI at 122.08 highlight an approach to overbought conditions. Stoch RSI diverges by flagging an oversold status, and BBP measured at 0.82 calls the tape overbought, underscoring a pronounced divergence across key momentum indicators.

Limited upside as sideways trade threatened by downside triggers

Over the next five sessions, the price is expected to trade within a typical volatility band between $5.28 and $5.77. The probability of a significant move above resistance is low, with less than a 20% chance of a breakout above $5.77. The baseline scenario projects a sideways oscillation anchored by $4.88 as immediate support, with sustained selling potentially accelerating if $5.28 is breached. A definitive bullish scenario would require a close above $5.77 to signal recovery, while a break below $5.28 heightens downside risk in view of persistent overbought readings and oscillator divergence.

Viktoras Karapetjanc, expert at Traders Union, sees Injective’s USDC integration as a clear step forward for network utility and adoption. Despite a sharp daily drop, he believes the project’s strengthening fundamentals and expanding infrastructure are constructive signals. The analyst notes ongoing bullish momentum and highlights key support at $4.88 as a potential anchor for price stability. He maintains a positive tactical outlook but stresses the importance of holding above immediate levels. "If Injective continues to expand on its ecosystem advances while price holds key supports, the medium-term outlook remains favorable for further growth," says Karapetjanc.

Earlier, analysts noted that Injective was exhibiting sustained bullish momentum despite mixed signals from overbought technical indicators, favoring a largely range-bound outlook. The current environment, highlighted by oscillator divergence and the impact of new ecosystem integrations, suggests traders should closely monitor the $5.28 support level as a potential trigger for accelerated downside or renewed volatility.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.